| The atypical antipsychotic olanzapine causes weight gain by targeting serotoninreceptor 2C. | J Clin Invest | 2017 Sep 1 | 28805659 |
| [Guidelines for the prescription of mood stabilizers for adolescents: Aliterature review]. | Encephale | 2017 Oct | 27871720 |
| Methods for using clinical laboratory test results as baseline confounders inmulti-site observational database studies when missing data are expected. | Pharmacoepidemiol Drug Saf | 2016 Jul | 27146273 |
| Metformin and berberine prevent olanzapine-induced weight gain in rats. | PLoS One | 2014 Mar 25 | 24667776 |
| Atypical antipsychotics and the neural regulation of food intake and peripheralmetabolism. | Physiol Behav | 2011 Sep 26 | 21664918 |
| Olanzapine effects on body composition, food preference, glucose metabolism andinsulin sensitivity in the rat. | Arch Physiol Biochem | 2011 Oct | 21671852 |
| Olanzapine, not resperidone, exacerbates beta-cell function and mass inovariectomized diabetic rats and estrogen replacement reverses them. | J Psychopharmacol | 2010 Jul | 19965940 |
| Autism. | BMJ Clin Evid | 2010 Jan 7 | 21729335 |
| Metabolic side effects of antipsychotic drug treatment--pharmacologicalmechanisms. | Pharmacol Ther | 2010 Jan | 19931306 |
| Additive effects of olanzapine and melanin-concentrating hormone agonism onenergy balance. | Behav Brain Res | 2010 Feb 11 | 19788900 |